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INTRODUCTION
Hereditary motor neuropathies (HMN) are a genetically and clinically heterogeneous group neuropathies, caused by length-dependent axonal degeneration of lower motor neurons typically without involvement of sensory neurons. Although they can hardly be distinguished from more common neuropathies on clinical grounds, dHMNs are considered a separate and rarer class of disorders. Patients usually present with distal atrophy and muscle weakness, whereas proximal involvement only develops later in the disease progression, for this they are also named distal HMN (dHMN) . Additional clinical features such as foot malformations and pyramidal signs can be present. dHMN is also referred to as distal spinal muscular atrophy (dSMA), a reflection of the commonly held but unproven belief that the pathology resides in the ventral horn of the spinal cord. (Rossor et al., 2012) .
The causative genes have implicated proteins with diverse functions such as protein misfolding (HSPB1, HSPB8, BSCL2), RNA metabolism (IGHMBP2, SETX, GARS), axonal transport (HSPB1, DYNC1H1, DCTN1) and cation-channel dysfunction (ATP7A and TRPV4) in motor-nerve disease. (Bansagi et al.2017) .
EMILINs are glycoproteins of the extracellular matrix strongly expressed in tissues where resilience and elastic recoil are prominent. The first member of this group, EMILIN-1, was identified as a component of elastic fibres at the interface between elastin and microfibrils and it is characterized by a unique arrangement of structural domains: an N-terminal microfibril interface domain, a coiled-coiled alpha-helical domain, a collagenous domain and a C-terminal globular or C1q domain (Colombatti et al., 2000) .
J o u r n a l P r e -p r o o f
Journal Pre-proof EMILIN1 (NM_007046) gene is made of 8 exons. The exons 2 and 3 are characterized by a peculiar cysteine-rich N-terminal unit that defines the EMI-domain. Exon 4 encodes for four coiled-coil structures and two leucine zippers, which depict a functional unit. The collagenous region of EMILIN-1 is encoded by exons 5, 6 and part of exon 7. Finally, the globular C1q domain is encoded by part of exon 7 and exon 8 (Colombatti et al., 2000) .
Recently, a missense mutation in exon 1 of the EMILIN1 gene (c.64G>A, p.[A22T]) was identified in a three-generation family with connective tissue disorder and sensorymotor neuropathy (Capuano et al., 2016; Rossor et al., 2017) . The 55-year-old proband presented with aortic aneurysms, bilateral lower leg and foot sensorimotor peripheral neuropathy and increased skin elasticity. The proband's mother had a history of bilateral lower extremity neuropathy (upper extremities reportedly unaffected), pes planus, easy bruising, and decreased clotting. The proband's son had a history of degenerative joint disease, foot neuropathy, and pes cavus. In skin biopsy of the proband, less EMILIN-1 was found with disorganized and abnormal coarse fibrils, aggregated deposits underneath the epidermis basal lamina, and dermal cells apoptosis.
We report on clinical, histopathological and functional consequences of a novel EMILIN1 missense in exon 4, c.748C>T [p.R250C], identified in a further autosomal dominant family of three children and their father featuring distal motor neuropathy selectively affecting the lower limbs and without signs of connective tissue disorder.
To confirm pathogenicity of this new missense mutation located in a coiled coil domain of the protein, we studied the coiling coil forming potential as well as expression of the mutated protein in skin fibroblasts and skeletal muscle derived nerve bundles.
Journal Pre-proof Lastly, we down-regulated the neurodevelopmental isoform emilin1a in zebrafish (Danio rerio) embryos to explore the role of mutant EMILIN1 in neuronal motor system function and development,
METHODS

Genetic Analysis
Genomic DNA was isolated from 1 ml of peripheral blood using QIAamp DNA Blood Midi (Qiagen) and sheared by sonication. DNA samples were enriched with Nextera Rapid Capture Expanded Exome which targets 62Mb of genomic DNA, including exons, untranslated regions (UTRs), and non-coding genes such as miRNA. Libraries were loaded into Paired Ends v3 flow cells on an Illumina cBot. This was followed by indexed paired-end sequencing on a HiSeq 2000 using SBS Kit v3 chemistry (Illumina).
Using CLC Genomics Workbench 7.5.1 (Qiagen), pair-end reads were mapped to the reference human genome sequence (GRch37/ hg19). Single-nucleotide variants (SNVs) and short deletions or insertions (indels) were identified by the same software using the probabilistic variant calling plugin. Variants were filtered according to genetic criteria for a very rare, highly penetrant autosomal dominant trait: 1) heterozygous shared; 2) MAF ≤ 0.0001, not reported in dbSNP147; 3) non-synonymous or affecting the splice site. Validation and parental origin of the resulting variants were assessed by Sanger sequencing.
In silico analysis
The p.
[R250C] mutation is in a region presenting several short coiled-coil forming sequences. A 30-residue-long sequence around the mutation was analyzed by COILS (Bioinformatic platform EXPASI, http://www.ch.embnet.org/cgi-J o u r n a l P r e -p r o o f Journal Pre-proof bin/COILS_form_parser # NCOILS version 1.0) and CCHMM_PROF (Fariselli et al., 2007) , the latter showing the highest precision in identifying coiled-coil domains among several other applications. Both programs recognized the submitted region as a potential coiled-coil forming sequence only when it was submitted in the WT form, whereas the sequence carrying the p.[R250C] mutation was not recognized as capable of forming coiled-coil structures.
Primary fibroblast cultures and immunofluorescence staining
Primary fibroblasts derived from skin biopsy of I-1, II-1 II-2, and an age-matched control donor (a 29-year-old healthy woman) were cultured in RPMI medium supplemented with 20% FBS. Cells were grown on glass coverslips in 6-well culture plates and after 7 days in culture immunostained with an anti-human EMILIN1 rabbit polyclonal antibody produced in our laboratories (AS556) (Capuano et al., 2016 ). An Alexa-488 conjugated anti rabbit antibody was then added to visualize EMILIN1 in green. Nuclei were stained with TOPRO (pseudocolored in blu) and the images were finally obtained at different focal planes by a true confocal scanner system (TCS SP8 FSU AOBS, Leica Microsystems, Wetzlar, Germany) equipped with a DMi8 CS microscope (Leica), using Leica confocal LAS AF SP8 software. Images were then processed and analyzed using Volocity software (Perkin Elmer, Milan, Italy).
Fluorescence intensity and quantification were evaluated by means of the Volocity software Version 6.1.1 (PerkinElmer Inc.,Waltham, MA, USA). The expression of EMILIN-1 was calculated as pixel positive area of at least four 63x acquired fields.
Corresponding values were expressed as mean ± SD.
Western blot J o u r n a l P r e -p r o o f Journal Pre-proof Patient-derived dermal fibroblasts were cultured for 7 days in duplicate. One was used to obtain matrix extracts and, accordingly, treated with 1% NP40 and solubilized with "sample buffer" (50 mM Tris-HCl pH6.8, 2% SDS, 10% glycerol, 0.2%, bromophenol blue) + 5% β-mercaptoethanol. The other replicate was used to normalize the corresponding matrix extract measuring the total protein amount (Biorad protein assay) of the whole cell lysate. Proteins from matrix extracts and total lysates were separated in two different gels (4-20% SDS PAGE, Criterion Precast gel, Biorad) and Western blot analysis was performed with AS556 anti-human EMILIN-1 rabbit polyclonal antibody and with anti-tubulin mouse monoclonal antibody to assess sample normalization (Sigma).
Immunofluorescence studies on muscle and skin section
Cryostat 7 um sections from snap frozen punch skin and muscle samples from patient I,1 and patient II,1 quadriceps respectively, were obtained according to standard procedure. Muscle and skin sections from healthy controls were also processed.
Muscle sections with visible nerve bundles were processes for Hematoxylin Eosin, Modified Gomori Trichrome stainings. Nuclei were counterstained with TO-PRO (pseudocolored in blue). Skin and muscle sections were processed for immunofluorescence with the following primary antibodies: 1:30 Mouse Monoclonal 1H2G8 anti human EMILIN1 (produced in our laboratories) (Capuano et al., 2016; Spessotto et al., 2003) Protein (NCL-L-S100) was used to confirm colocalization in the nerve structures.
Images were acquired using Zeiss Axioplan Imager M2.
Neuropathology
Sural nerve biopsy was perofrmed according to previosly published methodology and guidelines (Sommer C et al., 2008) Functional studies in zebrafish Adult male and female wild-type (WT) zebrafish (AB, Tg(Neurod1-GcAMP6f strains)
were maintained according to standard procedures (Westerfield, 2000) For the generation of zebrafish emilin1a knockdown, we used an already reported morpholino antisense oligonucleotides (MOs) targeting the splice site between exons 2 and 3 (spliceMO) (Tijssen et al., 2011) and synthetized with standard methodologies J o u r n a l P r e -p r o o f Journal Pre-proof (GeneTools, Philomath, OR) . Concentrations of MOs were carefully titrated to avoid nonspecific binding effects to assess specificity to emilin1a. After titration, we used, in all experiments, 6 ng/nl of spliceMO against emilin1a, as reported elsewhere (Tijssen et al., 2011) . Rescue experiments were performed through co-injection of 100pg of control, emilin1a and either human WT or mutant (mut R250C ) cRNAs with spliceMO at the same concentration used for the knockdown experiments. Each experiment was repeated at least three times if not otherwise stated.
Touch-evoked escape response was measured at 48 hpf on a semiquantitative scale from normal, wild-type, normal swimming, to mild, flicker of movement but no swimming;
to severe, no movement.
Coiling behavior was measured in embryos at 30hpf (n=20 for each experiment) using the Danioscope software (Noldus Information Technology, Wageningen, The Netherlands), while the locomotor tracking of 5dpf larvae was measured on morphants and control larvae (n=19 for each experiment) using the Daniovision system and the Ethovision XT software (Noldus Information Technology, Wageningen, The Netherlands). Each experiment was repeated three times.
Whole-mount immunohistochemistry, embryos were fixed in 4% PFA overnight at 4°C and stored in methanol. ZNP-1 (ab113545, Abcam) staining was performed as described previously (n=15) (Marchese et al., 2016) . Images of the brain defects were acquired using the pan-neuronal line Tg (Neurod1:GcAMP6f) and the ROI based quantification of fluorescence was made using ImageJ software. All the images were acquired using the stereomicroscope Leica M205FA (Leica, Wetzlar, Germany).
Statistical analysis
J o u r n a l P r e -p r o o f For functional studies on human samples, data are presented as mean ± SD. The Student's t test was used for the analysis of statistical significance. A p value < 0.05 was considered significant.
RESULTS
Subjects
Clinical features in this family are summarised in Table 1. A 56-year-old man (I-1) and his three children (II-1, II-2, II-3) age 19, 17 and 12 ( Figure 1A ) showed amyotrophy and weakness of the distal lower limbs, dating back to early childhood. Neurological development was overall normal, with the exception of mild floppiness in the first months of life, which however did not require medical attention. Compared with their father, the two oldest children displayed a more severe Ambulation was charachterized by pes valgus, bilateral steppage gait and bent knees, J o u r n a l P r e -p r o o f Journal Pre-proof particularly severe in patient II-1 and II-2 (Supplementary Video). Patellar tendon reflexes were increased and patients II-1, II-2 and II-3 also showed clonus.
Needle Electromyography (EMG) study in the distal muscles of the leg (tibial anterior and extensor digitorum brevis) in all showed not fibrillation potentials and slightly large, long duration and polyphasic (more than 30%) motor unit action potentials (MUAPs) with moderately decreased recruitment ( Figure 1D ). On nerve conduction studies, compound muscle action potential (CMAP) amplitudes were within normal lower limits but decreased compared to precedent exam two years before for peroneal nerve (from 3.8 mV to 3.0 mV for distal CMAP peroneal nerve) ( Figure 1D ). Sensory Nerve Action Potentials (SNAPs) showed normal amplitudes and latencies.
Quadriceps muscle biopsy performed in patient I-1 and II-1, showed variation in fiber size with angulated hypotrophic fibers. Groups of both type 2 and type 1 were also present at ATPase staining, thus confirming a neurogenic damage ( Figure 1E ). Sural nerve biopsy displayed slight reduction of the number of myelinated fibers, whereas unmyelintaed fibers were within the nomal range. We also observed unspecific changes in myelin morphology and thickess.
Muscle MRI of lower limbs from patient II-1 showed fatty substitution of soleus and tibialis posterior muscles, whereas muscles of the thight were not affected ( Figure 1F ).
Brain MRI in patients II-1 and II-2 detected a minor defect of giration in the cingulus without frank cortex abnormalities. Spine MRI was unremakable. Patients II-2 and II-3 also presented a low IQ for age. No patient showed evidence of pulmonary, vascular or cardiac disease, as evaluated by ultrasound. Tissue frailty or skin abnormalities were not detected. The 45-year-old mother (I-2) was asymptomatic and her neurological examination was normal. Sanger sequencing confirmed that the variant is heterozygous in the three siblings and in their affected father (I-1), whereas it is absent in the healthy mother (I-2).
[R250C] mutation is novel, absent in gnomAD database (http://gnomad.broadinstitute.org/), and predicted to be deleterious or probably damaging according to SIFT and POLYPHEN software respectively. According to ACMG criteria, the variant can be classified as pathogenetic (see Supplementary Table) .
Additionally it variant affects an evolutionarily highly conserved amino acid located in a region characterized by several short coiled-coil forming sequences. In silico analyses of this region with COILS (Bioinformatic platform EXPASI) and CCHMM_PROF (Fariselli et al., 2007) showed that p.[R250C] severely impairs the probabilities to form coiled-coil formation (Supplementary Figure A) .
Immunohistochemical studies in motor nerves and skin
We stained muscle sections from patient II-2 and age matched control with antibody against EMILIN-1 and documented a strong presence of EMILIN-1 in few intramuscular nerve bundles. Within these nerves we found EMILIN-1 expression around axons and in the epineurum. When co-immuno-stained with S100, a marker of J o u r n a l P r e -p r o o f Journal Pre-proof neuroectodermal components, EMILIN-1 appear to co-localize with S100, however no clear difference can be noted between patient and control (Figure 2 C) .
Skin section from patient I, 1 and healthy age matched control were stained with antibody against EMILIN-1. In the patient the presence of EMILIN-1 is reduced as compared to the control, where a finer and more branched staining is detected ( Figure   3A )
These combined data could suggest that the involvement of the peripheral nerves in EMILIN-1 mutated cases , is not due to reduced expression of the protein in nerve structures but possibly due to altered integrity of the connective tissue surrounding the nerves bundles as suggested in similar conditions (Voermans et al., 2009 ).
Fibroblasts Studies
To better confirm this hypothesis, we tested skin fibroblasts from the three siblings and documented quantitatively reduced extracellular deposition of EMILIN-1. The extracellular network appears less organized and formed by thinner and poorly ramified fibers, when compared to controls ( Figure 3B-D) . Accordingly, mutant cells release significantly lower amounts of EMILIN-1 in the extracellular matrix as demonstrated by Western Blotting of extracellular lysates ( Figure 3E ), suggesting a possible dysregulation of the EMILIN-1 secretion.
We also tested mutated fibroblasts for possible increase of ER stress as consequence of EMILIN-1 retention, as previously documented in cells from affected patients of the J o u r n a l P r e -p r o o f first described family (Capuano et al., 2016) . However, we did not find enhanced expression of BIP and CHOP transcripts (Supplementary Figure B) 
Functional studies in zebrafish
To further advocate a role of EMILIN-1 in peripheral nerves function and development we knocked-down emilin1a in zebrafish -the zebrafish isoform orthologue of human gene expressed in the central nervous system starting from the very early stages of the development (Milanetto et al., 2008 ) -adopting an already tested morpholino (Tijssen et al., 2011) .
We observed that emilin1a morphants at 48hpf displayed morphological defects, such as body curvature ( Figure 4A ) and an impairment of the brain development, with a statistically significant difference of the fluorescence in brain area compared to control siblings ( Figure 4B-C) . Immunofluorescence using ZNP1-antibody confirmed that downregulation of emilin1a was associated with a motor neuron defects showing an overall abnormal development of axons, with decreased arborization ( Figure 3D) .
Locomotor defects were observed at 30hpf, through the increase of the coiling frequency at least three times higher than control embryos, suggesting impaired neuronal excitability ( Figure 3E) ; furthermore also at 48hpf (Figure 4F-H EMILIN-1 is abundant in the cardiovascular system and important for correct functioning of vascular elastic fibers (Zacchigna et al., 2006; Zanetti et al., 2004) . Mice deficient for EMILIN1 show fine structural alterations of the elastic fibers and of the cells in the wall of large blood vessels and defects in lymphatic capillaries since EMILIN-1 is also a component of anchoring filaments (Danussi et al., 2013) . In zebrafish, expression of both Emilin-1 genes appears to be restricted to distinct territories of the central nervous system, thus suggesting a role for this protein in the development of the nervous system (Milanetto et al., 2008) .
In humans, a dominant form of connective tissue disorder with peripheral neuropathy has been recently associated with heterozygous dominant mutation in EMILIN1 (c.64G>A, p.[A22T]) (Capuano et al., 2016) . The main clinical features of the single family so far captured, included aortic aneurysm, hypermobility of joints and numerous tendon ruptures in the proband. The proband's mother had a history of easy bruising and decreased clotting. The proband's son had a history of degenerative joint disease. Of note, all the three affected members also presented signs of sensory-motor peripheral neuropathy with both demyelinating and axonal features, although results of nerve conduction studies were not provided.
The phenotype of our novel family is more exactly framed in a form of a length dependent motor neuropathy with some pyramidal features. We did not detect any signs of tissue frailty nor vessels or pulmonary pathology in this family. All the four affected patients showed analogous onset and progression. A lower amplitude of CMAPs of the peroneal and tibialis nerves was also documented and, in association with neurogenic J o u r n a l P r e -p r o o f alterations at EMG and muscle biopsy, pointed toward a diagnosis of distal hereditary motor neuropathy. Indeed, sensory nerve conductions were entirely normal. Increased tendon reflexes and pattern of gait, with adducted and bent knees, also suggested the involvement of the upper motor neuron.
Nerve histopathology could not confirm significant loss of axons or any other specific change in nerve morphology; however, the sural nerve is a purely sensory nerve and may not reflect the pathology in motor nerves. Nevertheless, in these sections unspecific alterations of myelin folding were noted and these limited findings could be interpreted as a result of an extracellular matrix perturbance. In a intramuscular nerve, we could detect positive EMILIN-1 immunostaining in perineurium and possibly schwann cells (Figure 2 D) . Indeed schwann cells produce extracellular matrix proteins and emilin secretion could be altered from schwann cells too. Further studies need to be performed to support this speculation. Albeit an alteration of schwann cells is expected to cause a demyelinating form of neuropathy, the nerve phenotype of this family is more of an axonal pure motor neuropathy. However, this is not unique as also mutations in myelin proteins as MPZ, have been associated to axonal forms of neuropathy.
Staining of muscle sections with antibody against EMILIN-1 demonstrated a robust expression of this protein within intramuscular nerve bundles (Figure 2 C) . However no difference can be noted between patient and control. These preliminary but original findings are in line with a putative role of EMILIN-1 in these tissues which, as consequence, are probably affected by mutations of the EMILIN1 gene.
In skin and skin fibroblasts from 3 patients we ascertained that the novel p. Lastly, we observed altered CNS development, impaired locomotion and axonal arborization from spinal cord motor neurons in emilin1a morphants. Whilst WT human and zebrafish cRNAs complemented the motor phenotype, the human p.[R250C] cRNA was unable to rescue impaired locomotion, a finding suggestive of a disease-related correlation. It is of note that in our family we did detect minor abnormalities of gyration, mild cognitive impairment and hyperreflexia which can recapitulate a concomitant CNS involvement, albeit not severe, and in line with the mild CNS alteration seen in zebrafish models. Findings of altered CNS with EMILIN1 mutation should be not too surprising as it is well known that several motor neuropathies share involvement of upper motor neuron and/or abnormal gyration as in cases harboring mutations in DYNC1H1 and BICD2 Fiorillo et al., 2014) . This J o u r n a l P r e -p r o o f Journal Pre-proof association however needs to be confirmed and could be of considerable interest as more families are identified.
In conclusion, we provided novel evidences for the role in EMILIN-1 in the nervous system and in disease stratus suggesting EMILIN1 as a possible genetic cause of distal motor neuropathy. We supported this result with genetic evidence in a second dominant family, prediction analysis on protein coiled coil formation, histological studies and in vitro and in vivo functional experiments. Moreover, we endorsed EMILIN-1 as important for the nervous system development, at least when the gene was knockeddown in zebrafish embryos. We expect that, as more patients are tested for variants in EMILIN1, the phenotypic spectrum may expand, and further genotype-phenotype correlation can be delineated. (1) and automatic analysis (2) of interference pattern suggested a neurogenic pattern mainly for extensor digitorum brevis muscle E: muscle biopsy sections from quadriceps of patient II-1 stained with ATPase 4.3 (upper picture) and Gomori Trichrome (lower picture). ATPase staining allows to distinguish the two different types of fibres (type 1 and type 2). In a normally innervated muscle, a checkboard pattern is expected. In case of axons loss, the pattern is altered and the fibres of the same type form larger groups which are innervated by the remaining axons. Additionally, type 1 atrophy can be also present. The picture shows moderate type grouping of both type 1 (dark) and type 2 (light) fibres (contours highlighted), with type 1 fibres being average smaller, suggesting axons loss due to the motor neuropathy. Gomori Trichrome staining can be used to detect the fibre shape. A normal muscle fibre if transversally cut has a regular polygonal shape. In case of myopathy or muscle dystrophy the damaged fibres appear rounded. In case of denervation, the damaged fibres can present angulated borders or appear elongated (ribbon shape). The Gomori Trichrome staining of this patient show that most of fibres have a normal polygonal morphology, few angulated and ribbon like fibres (asterisks) are also present suggesting an initial denervation process.  A missense mutation in the EMILIN1 gene has been associated with autosomal dominant connective tissue disorder and moto-sensory neuropathy in a single family.
FIGURES LEGEND
Figure 1
 We report a novel EMILIN1 missense mutation identified in a family featuring axonal motor neuropathy selectively affecting lower limbs.
 We localised EMILIN-1 protein in perineurum of motor nerve bundles.
 Skin fibroblasts displayed a reduced extracellular deposition of EMILIN-1 protein with a disorganized network of poorly ramified fibers. 
